Reverting Antibiotic Tolerance of Pseudomonas aeruginosa PAO1 Persister Cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Pan, Jiachuan ^a,b   Bahar, Ali Adem ^a,b   Syed, Haseeba ^a,b   Ren, Dacheng ^a,b  

^a Syracuse University   (United States)

^b SYRACUSE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 BROMO 5 (BROMOMETHYLENE) 3 METHYLFURAN 2(5H) ONE; ANTIBIOTIC AGENT; CARBENICILLIN; CIPROFLOXACIN; FURANONE DERIVATIVE; GENTAMICIN; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC TOLERANCE; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BIOFILM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TOLERANCE; GRAM NEGATIVE BACTERIUM; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTER CELL; PLANKTON; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; VIBRIO HARVEYI;

4-BUTYROLACTONE; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; BIOFILMS; CARBENICILLIN; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; GENES, BACTERIAL; GENTAMICINS; MICROBIAL SENSITIVITY TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; TETRACYCLINE; TOBRAMYCIN; TRANSCRIPTOME;

NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 84866685714     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045778     Document Type: Article

References (43)

1. Lewis K, (2010) Persister cells. Annu Rev Microbiol 64: 357-372.
2. Lewis K, (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5: 48-56.
3. Christensen SK, Pedersen K, Hansen FG, Gerdes K, (2003) Toxin-antitoxin loci as stress-response-elements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA. J Mol Biol 332: 809-819.
4. Christensen SK, Gerdes K, (2003) RelE toxins from bacteria and Archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA. Mol Microbiol 48: 1389-1400.
5. Gerdes K, Christensen SK, Løbner-Olesen A, (2005) Prokaryotic toxin-antitoxin stress response loci. Nat Rev Microbiol 3: 371-382.
6. Hayes F, (2003) Toxins-antitoxins: plasmid maintenance, programmed cell death, and cell cycle arrest. Science 301: 1496.
7. Hansen S, Lewis K, Vulić M, (2008) Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother 52: 2718-2726.
8. Mulcahy LR, Burns JL, Lory S, Lewis K, (2010) Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J Bacteriol 192: 6191.
9. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci 103: 8487.
10. LaFleur MD, Qi Q, Lewis K, (2010) Patients with long-term oral carriage harbor high-persister mutants of Candida albicans. Antimicrob Agents Chemother 54: 39.
11. Ojha AK, Baughn AD, Sambandan D, Hsu T, Trivelli X, et al. (2008) Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol 69: 164-174.
12. Pearson H, (2002) 'Superbug' hurdles key drug barrier. Nature 418: 469.
13. Mukamolova GV, Kaprelyants AS, Young DI, Young M, Kell DB, (1998) A bacterial cytokine. Proc Natl Acad Sci 95: 8916.
14. Allison KR, Brynildsen MP, Collins JJ, (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473: 216-220.
15. Lewis K, (2001) Riddle of biofilm resistance. Antimicrob Agents Chemother 45: 999-1007.
16. Lewis K, (2005) Persister cells and the riddle of biofilm survival. Biochem (Moscow) 70: 267-274.
17. Spoering AL, Lewis K, (2001) Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 183: 6746-6751.
18. Moker N, Dean CR, Tao J, (2010) Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol 192: 1946-1955.
19. Pan J, Ren D, (2009) Quorum sensing inhibitors: a patent overview. Expert Opin Ther Pat 19: 1581-1601.
20. Han Y, Hou S, Simon KA, Ren D, Luk YY, (2008) Identifying the important structural elements of brominated furanones for inhibiting biofilm formation by Escherichia coli. Bioorg Med Chem Lett 18: 1006-1010.
21. Hou S, Duo M, Han Y, Luk Y-Y, Ren D (2009) Inhibiting microbial biofilm formation by brominated furanones. Minneapolis, Minnesota. ASM International. 6-10.
22. Surette MG, Bassler BL, (1998) Quorum sensing in Escherichia coli and Salmonella typhimurium. Proc Natl Acad Sci 95: 7046.
23. Hentzer M, Riedel K, Rasmussen TB, Heydorn A, Andersen JB, et al. (2002) Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiol 148: 87-102.
24. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
25. Wang R, Starkey M, Hazan R, Rahme LG, (2012) Honey's ability to counter bacterial infections arises from both bactericidal compounds and QS inhibition. Front Microbiol 3: 144.
26. Taylor P, Schoenknecht F, Sherris J, Linner E, (1983) Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother 23: 142-150.
27. Andrews JM, (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48: 5-16.
28. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S, (2004) Bacterial persistence as a phenotypic switch. Science 305: 1622.
29. Gefen O, Balaban NQ, (2009) The importance of being persistent: heterogeneity of bacterial populations under antibiotic stress. FEMS Microbiol Rev 33: 704-717.
30. Mah TF, O'Toole GA, (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9: 34-39.
31. Goodrich AF, Steege DA, (1999) Roles of polyadenylation and nucleolytic cleavage in the filamentous phage mRNA processing and decay pathways in Escherichia coli. RNA 5: 972-985.
32. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K, (2004) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186: 8172-8180.
33. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, et al. (2006) Persisters: a distinct physiological state of E. coli. BMC Microbiol 6: 53.
34. Bomberger JM, Ye S, MacEachran DP, Koeppen K, Barnaby RL, et al. (2011) A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system. PLoS Pathog 7: e1001325.
35. MacEachran DP, Stanton BA, O'Toole GA, (2008) Cif is negatively regulated by the TetR family repressor CifR. Infect Immun 76: 3197.
36. Brazas MD, Hancock REW, (2005) Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49: 3222-3227.
37. Hentzer M, Wu H, Andersen JB, Riedel K, Rasmussen TB, et al. (2003) Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J 22: 3803-3815.
38. Ren D, Sims JJ, Wood TK, (2001) Inhibition of biofilm formation and swarming of Escherichia coli by (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2 (5H)-furanone. Environ Microbiol 3: 731-736.
39. Pabdee AB, Jacob F, Monod J, (1959) The genetic control and cytoplasmic expression of "inducibility" in the synthesis of β-galactosidase by E. Coli. J Mol Biol 1: 156-178.
40. Niepa THR, Gilbert JL, Ren D, (2012) Controlling Pseudomonas aeruginosa persister cells by weak electrochemical currents and synergistic effects with tobramycin. Biomaterials 33: 7356-7365.
41. Chen CY, Nace GW, Irwin PL, (2003) A 6×6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli. J Microbiol Meth 55: 475-479.
42. Chen X, Zhang M, Zhou C, Kallenbach NR, Ren D, (2011) Control of bacterial persister cells by Trp/Arg-containing antimicrobial peptides. Appl Environ Microbiol 77: 4878-4885.
43. Duo M, Zhang M, Luk YY, Ren D, (2010) Inhibition of Candida albicans growth by brominated furanones. Appl Microbiol Biotechnol 85: 1551-1563.